Search

Your search keyword '"Ader, Florence"' showing total 468 results

Search Constraints

Start Over You searched for: Author "Ader, Florence" Remove constraint Author: "Ader, Florence" Search Limiters Peer Reviewed Remove constraint Search Limiters: Peer Reviewed Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
468 results on '"Ader, Florence"'

Search Results

1. Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

2. Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective study

4. Legionnaires Disease in Solid Organ Transplant Recipients: A Decade-Long Nationwide Study in France

5. Improving Diagnosis of Pulmonary Mucormycosis: Leads From a Contemporary National Study of 114 Cases

6. Ensuring quality control in a COVID-19 clinical trial during the pandemic: The experience of the Inserm C20–15 DisCoVeRy study

8. Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials

11. Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial

12. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses

13. Co-infection with Legionella and SARS-CoV-2, France, March 2020

14. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

16. Health crisis: What opportunities for clinical drug research?

17. Acyclovir treatment of varicella-zoster virus meningeal infections and acute kidney injury: a multicentre case series study.

19. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19

21. New Approaches to Manage Infections in Transplant Recipients: Report From the 2023 GTI (Infection and Transplantation Group) Annual Meeting

23. Improving Diagnosis of Pulmonary Mucormycosis

25. A retrospective comparison of COVID-19 and seasonal influenza mortality and outcomes in the ICUs of a French university hospital

26. Association of baseline white blood cell counts with tuberculosis treatment outcome: a prospective multicentered cohort study

27. Efficacy and Safety of Revaccination against Tetanus, Diphtheria, Haemophilus influenzae Type b and Hepatitis B Virus in a Prospective Cohort of Adult Recipients of Allogeneic Hematopoietic Stem Cell Transplantation

29. Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial

30. Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial

31. Legionnaire’s disease in solid organ transplant recipients: a decade nationwide study in France

37. Association between SARS‐CoV‐2 viral kinetics and clinical score evolution in hospitalized patients.

38. Effect of Swine Glyco-humanized Polyclonal Neutralizing Antibody on Survival and Respiratory Failure in Patients Hospitalized With Severe COVID-19: A Randomized, Placebo-Controlled Trial.

39. Prospective Whole-Genome Sequencing in Tuberculosis Outbreak Investigation, France, 2017-2018

40. Suboptimal exposure to fluconazole in critically ill patients: Pharmacokinetic analysis and determinants

41. Implementation of a centralized pharmacovigilance system in academic pan‐European clinical trials: Experience from EU‐Response and conect4children consortia

43. Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortia

45. Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022

46. Distinct Immune Reconstitution Profiles Captured by Immune Functional Assays at 6 Months Post Allogeneic Hematopoietic Stem Cell Transplantation

48. Cidofovir in the Treatment of BK Virus–Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation

49. Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19

50. Management of pharmacovigilance during the COVID-19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial

Catalog

Books, media, physical & digital resources